Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study
- Resource Type
- Source
- BMC Infectious Diseases
BMC Infectious Diseases, BioMed Central, 2012, 13, pp.471
D:A:D study Group 2013, ' Non-AIDS defining cancers in the D:A:D Study-time trends and predictors of survival : A cohort study ', BMC Infectious Diseases, vol. 13, no. 1, 471 . https://doi.org/10.1186/1471-2334-13-471
BMC INFECTIOUS DISEASES
BMC Infectious Diseases, 13(1):471. BioMed Central
BMC infectious diseases, 13
Worm, Signe W; Bower, Mark; Reiss, Peter; Bonnet, Fabrice; Law, Matthew; Fätkenheuer, Gerd; d’Arminio Monforte, Antonella; Abrams, Donald I; Grulich, Andrew; Fontas, Eric; Kirk, Ole; Furrer, Hansjakob; Wit, Stephane; Phillips, Andrew; Lundgren, Jens D; Sabin, Caroline A (2013). Non-AIDS defining cancers in the D:A:D Study-time trends and predictors of survival: a cohort study. BMC infectious diseases, 13(471), p. 471. BioMed Central 10.1186/1471-2334-13-471
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
BMC Infectious Diseases, 13(1):471. BMC
BMC infectious diseases, 13(1). BioMed Central
BMC Infectious Diseases, 2012, 13, pp.471
Worm, Signe W; Bower, Mark; Reiss, Peter; Bonnet, Fabrice; Law, Matthew; Fätkenheuer, Gerd; et al.(2013). Non-AIDS defining cancers in the D:A:D Study-time trends and predictors of survival: a cohort study. BMC Infectious Diseases, 13(1), 471. doi: http://dx.doi.org/10.1186/1471-2334-13-471. Retrieved from: http://www.escholarship.org/uc/item/9ks6r0xt - Subject
Male Kaplan Meier method proportional hazards model SWISS HIV COHORT HIV Infections 0302 clinical medicine 1108 Medical Microbiology cancer diagnosis Prospective Studies Pathologie maladies infectieuses cancer survival ComputingMilieux_MISCELLANEOUS IMMUNODEFICIENCY Incidence Sciences bio-médicales et agricoles cohort analysis Prognosis 3. Good health [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology D:A:D Study Group risk factor 030220 oncology & carcinogenesis Cohort Cohort study prospective study Human medicine.medical_specialty Prognosi HIV Non-AIDS defining cancers Trends Adult Anti-HIV Agents Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count Female Humans Kaplan-Meier Estimate Middle Aged Neoplasms Infectious Diseases non AIDS defining cancer Microbiology cancer prognosis 03 medical and health sciences death Anal cancer Risk factor Proportional hazards model HIV Infections -- drug therapy -- mortality Anti-HIV Agent Anti-HIV Agents/therapeutic use Antiretroviral Therapy HIV Infections/drug therapy/ mortality medicine.disease major clinical study mortality Prospective Studie age Neoplasms -- mortality observational study cancer incidence anus cancer gender Trend Medicine and Health Sciences HIV Infection 030212 general & internal medicine Prospective cohort study survival prediction RISK INFECTED PATIENTS ACTIVE ANTIRETROVIRAL THERAPY Incidence (epidemiology) article Human immunodeficiency virus infected patient ANAL CANCER Non-AIDS defining cancer Anti-HIV Agents -- therapeutic use ethnicity 0605 Microbiology Research Article Hodgkin disease UNITED-STATES 610 Medicine & health smoking NO MALIGNANCIES Internal medicine mental disorders medicine follow up Highly Active controlled study Lung cancer HODGKINS-DISEASE disseminated cancer business.industry 1103 Clinical Sciences BONE-MARROW-TRANSPLANTATION Surgery lung cancer 3121 General medicine, internal medicine and other clinical medicine Neoplasm business - Language
- English
- ISSN
- 1471-2334